CONTINUUM Newsletter

CONTINUUM | Drug discovery is an iterative, integrated continuum of activities ranging from target identification and validation to lead optimization, preclinical, and clinical testing. This approach merges chemistry, biology, and medicine with technologies like AI to accelerate discovery and improve success rates from bench to bedside. This dynamic newsletter provides a monthly pulse on all things drug discovery at Emory (and beyond!).

CONTINUUM Newsletter

October 2026

Highlights for this Issue: Breast Cancer Awareness Month | FDA Approves Camizestrant and Expands the Approval of Tucitinib for the Treatment of Advanced or Metastatic Breast Cancer | Winship 5K Update

click here to read more
camizestrant chemical structure in front of the breast cancerpink ribbon

September 2026

Highlights for this Issue: Accepting Applications for the 2027 CNM Therapeutic Advancement Awards | Daraxonrasib Receives FDA Approval | OX2R Agonists for the Treatment of Narcolepsy |Winship 5K T-Shirt Design Revealed

Click here to read more
chemical structure of orzeyful over the image of a human brain

August 2026

Highlights for this Issue: Accepting Applications for the 2027 CNM Therapeutic Advancement Awards | Antiviral Drug Development at Emory - A Perspective by George Painter | Pipeline Update from Mingji Dai |Of Monsters and Medicine - The Evolution of GLP-1R Agonists | Industry Hights - FDA Approval of Islatravir

Click Here to Read More
trophy with banner for 2027 therapeutic advancement Awards

June 2026

Highlights for this Issue: Industry Highlights: Vepdegestrant & Daraxonrasib | Alzheimer's Awareness Month | Event Highlight: Inaugural Tri-Institutional Trainee Symposium

Click Here to Read More
award tropy

May 2026

Highlights for this Issue: Event Recaps - 2026 3D Symposium and Trainee Symposium | Pipeline Update from Dennis Liotta | Women's Health Awareness Month

Click here to read more
Bright, colorful pills float against a yellow background with text: "2026 Emory 3D Symposium. The Future of Therapeutic Innovation, Friday, April 3rd." Emory logo below.

April 2026

Highlights for this Issue: Clinical Trials to Watch at Emory | Pipeline Update from Yong Wan

Click here to read more
Headshots of (left to right): Yong Wan, Mingji Dai, and Yueming Zhu.

March 2026

Highlights for this Issue: Clinical Trials to Watch in 2026 | Pipeline Update from Xiulei Mo | Brain Injury Awareness Month

Click here to read more
Illustration of SMAD4 and SMAD3 proteins interacting. Pink and blue ribbons represent proteins linked by molecules, labeled neo-C361 and neoCMG101.

February 2026

Highlights for this Issue: Pipeline Update from Andrey Ivanov | A Brief Look at 2025 FDA Approvals (and an associated clinical trial at Winship!)

Click here to read more
The word 'Continuum' is centered with glowing, intertwined neon light trails in blue, pink, and orange on a dark background, evoking a futuristic and dynamic feel. Emory Center for New Medicines logo is at the bottom.